BVT Knock-Out BRM/ DE000VD2G9Q3 /
7/8/2024 9:45:15 PM | Chg.-0.01 | Bid10:00:09 PM | Ask10:00:09 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.84EUR | -0.54% | - Bid Size: - |
- Ask Size: - |
BRISTOL-MYERS SQUIBB... | 59.72 - | 12/31/2078 | Put |
GlobeNewswire
6/19
Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Re...
GlobeNewswire
6/18
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire
6/17
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increa...
GlobeNewswire
6/17
Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angel...
GlobeNewswire
6/14
Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...
GlobeNewswire
6/11
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire
6/11
Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001
GlobeNewswire
6/10
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire
5/31
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire
5/30
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire
5/23
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...